MAI Capital Management’s First Trust Enhanced Short Maturity ETF FTSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$803K Sell
13,440
-1,182
-8% -$70.8K ﹤0.01% 1082
2026
Q1
$874K Buy
14,622
+352
+2% +$21.1K ﹤0.01% 821
2025
Q4
$855K Sell
14,270
-842
-6% -$50.5K ﹤0.01% 787
2025
Q3
$905K Sell
15,112
-330
-2% -$19.8K 0.01% 736
2025
Q2
$925K Hold
15,442
0.01% 673
2025
Q1
$924K Sell
15,442
-1,060
-6% -$63.5K 0.01% 639
2024
Q4
$986K Buy
+16,502
New +$988K 0.01% 641
2021
Q3
Sell
-95,778
Closed -$5.74M 831
2021
Q2
$5.74M Sell
95,778
-4,055
-4% -$243K 0.11% 144
2021
Q1
$5.99M Sell
99,833
-4,361
-4% -$262K 0.13% 129
2020
Q4
$6.26M Buy
+104,194
New +$6.26M 0.16% 117

Other funds holding FTSM

MAI Capital Management's FTSM Position: Q2 2026 in Review

MAI Capital Management reduced its First Trust Enhanced Short Maturity ETF (FTSM) stake by 8.1% in Q2 2026, selling an estimated $70.8K and leaving 13,440 shares worth $803K. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

MAI Capital Management first reported a position in FTSM in Q4 2020 and has held it in 10 quarters since. The position peaked at $6.26M in Q4 2020. 421 funds tracked by Wall St. Rank hold FTSM as of Q2 2026.

  • MAI Capital Management held 13,440 shares of First Trust Enhanced Short Maturity ETF worth $803K as of Q2 2026.
  • MAI Capital Management sold 1,182 First Trust Enhanced Short Maturity ETF shares in Q2 2026, an estimated $70.8K.
  • First Trust Enhanced Short Maturity ETF made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1082 holding.
  • MAI Capital Management first reported a position in First Trust Enhanced Short Maturity ETF in Q4 2020 and has held it in 10 quarters since.
  • MAI Capital Management's First Trust Enhanced Short Maturity ETF position peaked at $6.26M in Q4 2020.
  • 421 funds tracked by Wall St. Rank held First Trust Enhanced Short Maturity ETF as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.